HPV-STI Genomap Test Kit

Cervical Cancer & STI Screening with HPV-STI Genomap Kit

Revolutionizing Cervical Cancer & STI Screening with HPV-STI Genomap Kit

Cervical cancer remains a pressing public health concern in India, with over 123,907 new cases and 77,348 fatalities annually (WHO 2023). Globally, more than 1 million STIs are acquired daily, with over 95% of cervical cancer cases attributed to HPV (Human Papillomavirus). Co-infections with HPV and other STIs amplify reproductive health risks and can speed up the progression to cervical cancer.

Challenges with Traditional HPV & STI Testing Methods

Conventional molecular tests-such as multiple PCRs-are limited by:

  • Restricted multiplexing capabilities
  • Incomplete genotyping information
  • Prolonged turnaround and hands-on times
  • Difficulty in detecting co-infections
  • Increased risk of false positives from contamination

Why Choose NGS for HPV and STI Detection?Why Choose NGS for HPV and STI Detection

Next-Generation Sequencing (NGS) addresses these gaps with:

  • High-throughput detection of multiple pathogens in one test
  • Accurate genotyping for HPV and STI strains
  • Simultaneous identification of co-infections
  • Enhanced support for clinical decision-making
HPV-STI Genomap Test Kit

Introducing UNCODED’s HPV-STI Genomap Test Kit

The HPV-STI Genomap is a single-assay NGS-based test kit designed to detect and genotype a broad spectrum of HPV and STI pathogens.

Advanced NGS Test for Comprehensive HPV and STI Genotyping

  • Utilizes amplicon-based multiplex PCR for enriched detection
  • Targets 41 pathogens: 28 HPV types and 13 STI pathogens
  • One-tube protocol ensures high-throughput efficiency
  • Seamless integration with all Illumina platforms
  • Unified workflow covering enrichment, sequencing, and reporting

Compatible with:

  • iSeq 100
  • MiniSeq™
  • MiSeq™
  • MiSeq i100 Series
  • NextSeq™

Why UNCODED’s HPV-STI Kit Stands Out

UNCODED delivers a robust and scalable NGS-based STI genotyping kit designed for high accuracy and flexible application:

  • Precise genotype-level results for HPV and STI targets
  • Supports routine diagnostics, public health surveillance, and research use
  • Detects co-infections with high specificity
  • Tailored for cervical cancer screening and STI tracking in India and globally
HPV Genotyping Panel

HPV Genotyping Panel

High-Risk & Probably High-Risk Types:

Associated with 99.7% of cervical cancer cases:

16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 (68a, 68b) 73, 26, 53, 82

Low-Risk Types:

Linked to benign conditions like genital warts:

6, 11, 40, 42, 43, 44, 55, 61, 81, 83

Why Choose UNCODED’s HPV-STI Genomap

Why Choose UNCODED’s HPV-STI Genomap?

UNCODED’s HPV-STI Genomap is a powerful testing solution based on Next-Generation Sequencing (NGS). It helps labs detect and study HPV and other sexually transmitted infections (STIs) more accurately and efficiently.
This advanced platform is fast, scalable, affordable, and highly accurate—making it ideal for modern pathogen testing.

Designed for NGS-enabled laboratories, UNCODED simplifies the entire process—from identifying infections to analyzing and reporting results.
With just one test, labs can detect and identify different types of HPV and STIs, removing the need to run separate tests for each.

This all-in-one approach saves time, increases lab productivity, and delivers consistent, reliable results.

UNCODED provides high-quality data that can be used in routine diagnostics, lab monitoring, and large-scale health studies.
It helps healthcare professionals and public health teams make informed decisions quickly—whether responding to outbreaks, planning interventions, or monitoring disease trends.

HPV Genotyping Panel

Applications of HPV-STI Genomap: Promoting Excellence in Clinical, Research & Public Health

UNCODED’s advanced bioinformatics and automation tools significantly boost the speed and efficiency of both diagnostics and research workflows.
This enables faster discovery, better decision-making, and supports everything from individual patient diagnosis to high-level research studies.
That’s why UNCODED’s HPV-STI Genomap is a trusted solution for clinical, research, and public health laboratories worldwide

Comprehensive Clinical Diagnostics

Detect and genotype multiple HPV and STI pathogens from a single clinical specimen—enabling better patient management and co-infection insights.

Epidemiological Surveillance & Population Studies

 Track pathogen prevalence, genotype shifts, and trends to support outbreak preparedness and public health policy.

Translational and Precision Medicine Research

Conduct genotype-driven analysis on infection behavior, resistance mechanisms, and clinical outcomes to inform personalized medicine.

Vaccine Evaluation & Longitudinal Monitoring

Assess infection persistence/clearance and vaccine efficacy by tracking genotype trends over time.

Reference Lab & Quality Assurance

Serve as a reproducible, validated framework for assay benchmarking, lab accreditation, and multi-center research collaboration.

Ordering Details
Catalog No.  Reaction 
10215  96 
Ordering Details of HPV STI Genomap
Storage Condition

20° C

Frequently Asked Questions

Curious about workflow, accuracy, or compatibility? Find all your answers here

What are the challenges of 16S V3-V4?

Lorem ipsum dolor sit amet consectetur. Dolor aenean lorem integer nunc at nascetur enim. At porta eu imperdiet porta condimentum vitae in lacus. Amet placerat senectus justo integer nulla lobortis bibendum sed quam. Morbi consequat iaculis et est elementum in.

Lorem ipsum dolor sit amet consectetur. Dolor aenean lorem integer nunc at nascetur enim. At porta eu imperdiet porta condimentum vitae in lacus. Amet placerat senectus justo integer nulla lobortis bibendum sed quam. Morbi consequat iaculis et est elementum in.

Lorem ipsum dolor sit amet consectetur. Dolor aenean lorem integer nunc at nascetur enim. At porta eu imperdiet porta condimentum vitae in lacus. Amet placerat senectus justo integer nulla lobortis bibendum sed quam. Morbi consequat iaculis et est elementum in.

Learn more about : HPV-STI Genomap

Download these resources for more information on the HPV-STI Genomap

HPV-STI Genomap

According to the World Health Organization, HPV causes over 95% of cervical cancer cases, and over 1 million STIs occur globally each day
Scroll to Top

Send Product Enquiry

Product Description

More Product specifications